Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma

NCT04102150

Conditions
Adult T-Cell Leukemia/Lymphoma, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
  • Ehime University Hospital Tōon-shi, Ehime, Japan
  • Kyushu University Hospital Fukuoka, Japan
View all 24 locations
View Trial Details
Completed

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

NCT01638533

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +125 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View Trial Details
Completed

A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

NCT05597085

Conditions
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +23 more
Locations
  • Fortis Memorial Research Institute Gurugram, Haryana, India
  • Malabar Cancer Center Thalassery, Kerala, India
  • Rajiv Gandhi Cancer Institute and Research Centre New Delhi, National Capital Territory of Delhi, India
  • Indo-American Cancer & Research Centre Hyderabad, Telangana, India
View Trial Details
Completed

Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India

NCT03476655

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Apollo Hospitals International Limited Ahmedabad, India
  • Healthcare Global (HCG) Hospital Bangalore, India
  • Fortis Memorial Research Institute Gurgaon, India
  • Basavatarakam Indo-American Hospital Hyderabad, India
View Trial Details
Completed

Ofatumumab & Ibrutinib + Allogeneic Bone Marrow Transplant or Consolidation in High Risk Chronic Lymphocytic Leukemia

NCT02388048

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +24 more
Locations
  • Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Provincia, Italy
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Area Vasta N. 5 Ascoli Piceno - S. Benedetto Del Tronto, Presidio Ospedaliero Av5 Osp. Gen. Prov.Le "C.G.Mazzoni" - Uoc Ematologia Ascoli Piceno, Italy
  • Nuovo Record Esporta in Excel Stampa Esporta in file di testo Mostra Informazioni Record Multi edit Stato dello studio presso il centro records: 28 Record 1/28 su 28 direzione di ordinamento Centro (CIC) direzione di ordinamento Sperimentatore Pri Bologna, Italy
View all 35 locations
View Trial Details

Related conditions